CHICAGO — New target therapies and improvements in surgical techniques are leading to a change in the expectations and outcomes of patients with thyroid eye disease.
“However, the more we learn about this disease, the more we understand that every patient is different, and no treatment, medical or surgical, works for everybody,” Sara Wester, MD, FACS, said at the American Academy of Ophthalmology meeting.
Treatment strategies are based on two key aspects of the disease: activity and severity. Treating early in the disease is important because the final phase of stable,